LFVAX | VISVX | LFVAX / VISVX | |
Total Expense Ratio | 1.28 | 0.19 | 674% |
Annual Report Gross Expense Ratio | 1.35 | 0.19 | 711% |
Fund Existence | 25 years | 27 years | - |
Gain YTD | -1.743 | 6.700 | -26% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1500 | 3000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 88.7M | 59.1B | 0% |
Annual Yield % from dividends | 0.00 | 1.88 | - |
Returns for 1 year | -5.63 | 6.93 | -81% |
Returns for 3 years | 19.66 | 44.60 | 44% |
Returns for 5 years | 34.47 | 79.69 | 43% |
Returns for 10 years | -14.70 | 113.89 | -13% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DHY | 2.09 | 0.03 | +1.46% |
Credit Suisse High Yield | |||
SEIM | 45.14 | -0.03 | -0.07% |
SEI Enhanced US Large Cap Momt Fac ETF | |||
KAUG | 26.08 | -0.12 | -0.45% |
Innovator U.S. Small Cp Pwr Buf ETF -Aug | |||
IEMG | 66.73 | -0.48 | -0.71% |
iShares Core MSCI Emerging Markets ETF | |||
CBLS | 28.62 | -0.28 | -0.98% |
Clough Hedged Equity ETF |